Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastases

Por Fabi, Alessandra, Vidiri, Antonello
Publicado no Transl Lung Cancer Res (2016)

First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?

Por Fabi, Alessandra, Malaguti, Paola, Vari, Sabrina, Cognetti, Francesco
Publicado no J Exp Clin Cancer Res (2016)

The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine

Por Maschio, Marta, Dinapoli, Loredana, Vidiri, Antonello, Pace, Andrea, Fabi, Alessandra, Pompili, Alfredo, Carapella, Maria Carmine, Jandolo, Bruno
Publicado em 2009

The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma

Por Villani, Veronica, Casini, Beatrice, Pace, Andrea, Prosperini, Luca, Carapella, Carmine M., Vidiri, Antonello, Fabi, Alessandra, Carosi, Mariantonia
Publicado no Dis Markers (2015)

HCP-05 COMBINED MANAGEMENT AND THE ROLE OF COMORBIDITIES IN ELDERLY GLIOBLASTOMA

Por Carapella, Carmine, Villani, Veronica, Zucchella, Chiara, Telera, Stefano, Sperduti, Isabella, Vidiri, Antonello, Fabi, Alessandra, Marucci, Laura, Pace, Andrea
Publicado no Neuro Oncol (2015)

Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation

Por Maselli, Angela, Capoccia, Sara, Pugliese, Patrizia, Raggi, Carla, Cirulli, Francesca, Fabi, Alessandra, Malorni, Walter, Pierdominici, Marina, Ortona, Elena
Publicado no Oncoimmunology (2015)

Quantitative analysis of CT-perfusion parameters in the evaluation of brain gliomas and metastases

Por Di Nallo, Anna Maria, Vidiri, Antonello, Marzi, Simona, Mirri, Alessandra, Fabi, Alessandra, Carapella, Carmine Maria, Pace, Andrea, Crecco, Marcello
Publicado em 2009

NI-11 THE POTENTIAL ROLE OF (18)F-FDOPA PET IMAGING IN THE EVALUATION OF LOW-GRADE GLIOMAS

Por Carapella, Carmine, Chiaravalloti, Agostino, Villani, Veronica, Vidiri, Antonello, Piludu, Francesca, Terrenato, Irene, Fabi, Alessandra, Schillaci, Orazio, Pace, Andrea, Floris, Roberto
Publicado em 2014

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

Por Lazzaro, Carlo, Bordonaro, Roberto, Cognetti, Francesco, Fabi, Alessandra, De Placido, Sabino, Arpino, Grazia, Marchetti, Paolo, Botticelli, Andrea, Pronzato, Paolo, Martelli, Elisa
Publicado em 2013

Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation

Por Vidiri, Antonello, Pace, Andrea, Fabi, Alessandra, Maschio, Marta, Latagliata, Gaetano Marco, Anelli, Vincenzo, Piludu, Francesca, Carapella, Carmine Maria, Giovinazzo, Giuseppe, Marzi, Simona
Publicado em 2012

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination wit...

Por Fabi Alessandra, Russillo Michelangelo, Ferretti Gianluigi, Metro Giulio, Nisticò Cecilia, Papaldo Paola, De Vita Ferdinando, D’Auria Giuliana, Vidiri Antonello, Giannarelli Diana, Cognetti Francesco
Publicado em 2012-10-01

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination wit...

Por Fabi, Alessandra, Russillo, Michelangelo, Ferretti, Gianluigi, Metro, Giulio, Nisticò, Cecilia, Papaldo, Paola, De Vita, Ferdinando, D’Auria, Giuliana, Vidiri, Antonello, Giannarelli, Diana, Cognetti, Francesco
Publicado em 2012

Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients

Por Fabi, Alessandra, Giannarelli, Diana, Malaguti, Paola, Ferretti, Gianluigi, Vari, Sabrina, Papaldo, Paola, Nisticò, Cecilia, Caterino, Mauro, De Vita, Roy, Mottolese, Marcella, Iacorossi, Laura, Cognetti, Francesco
Publicado no Drug Des Devel Ther (2015)

Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting

Por Bossi, Paolo, Cortinovis, Diego, Cossu Rocca, Maria, Roila, Fausto, Seminara, Patrizia, Fabi, Alessandra, Canova, Stefania, Verri, Elena, Fatigoni, Sonia, Iannace, Alessandro, Macchi, Fabio, Ripamonti, Carla
Publicado no J Altern Complement Med (2016)

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, pha...

Por Celio, Luigi, Frustaci, Sergio, Denaro, Angela, Buonadonna, Angela, Ardizzoia, Antonio, Piazza, Elena, Fabi, Alessandra, Capobianco, Alba Maria, Isa, Luciano, Cavanna, Luigi, Bertolini, Alessandro, Bichisao, Ettore, Bajetta, Emilio
Publicado em 2010

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation

Por Fabi, Alessandra, Metro, Giulio, Russillo, Michelangelo, Vidiri, Antonello, Carapella, Carmine Maria, Maschio, Marta, Cognetti, Francesco, Jandolo, Bruno, Mirri, Maria Alessandra, Sperduti, Isabella, Telera, Stefano, Carosi, Mariantonia, Pace, Andrea
Publicado em 2009

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

Por Novelli, Flavia, Milella, Michele, Melucci, Elisa, Di Benedetto, Anna, Sperduti, Isabella, Perrone-Donnorso, Raffaele, Perracchio, Letizia, Venturo, Irene, Nisticò, Cecilia, Fabi, Alessandra, Buglioni, Simonetta, Natali, Pier Giorgio, Mottolese, Marcella
Publicado em 2008

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Por Russillo Michelangelo, Nisticò Cecilia, Milella Michele, Carlini Paolo, Sperduti Isabella, Fabi Alessandra, Puglisi Fabio, Vaccaro Vanja, Bria Emilio, Cuppone Federica, Papaldo Paola, Ferretti Gianluigi, Aapro Matti, Giannarelli Diana, Cognetti Francesco
Publicado em 2011-05-01

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Por Cuppone, Federica, Bria, Emilio, Vaccaro, Vanja, Puglisi, Fabio, Fabi, Alessandra, Sperduti, Isabella, Carlini, Paolo, Milella, Michele, Nisticò, Cecilia, Russillo, Michelangelo, Papaldo, Paola, Ferretti, Gianluigi, Aapro, Matti, Giannarelli, Diana, Cognetti, Francesco
Publicado em 2011

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Por Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Caserta, Claudia, Fabi, Alessandra, Clavarezza, Matteo, Maiello, Evaristo, Eoli, Marica, Lombardi, Giuseppe, Monteforte, Marta, Proietti, Emanuela, Agati, Raffaele, Eusebi, Vincenzo, Franceschi, Enrico
Publicado no Neuro Oncol (2016)